| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033464027 |
| P356 | DOI | 10.1186/S12916-015-0382-8 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s12916-015-0382-8 |
| P932 | PMC publication ID | 4482312 |
| P698 | PubMed publication ID | 26103968 |
| P5875 | ResearchGate publication ID | 279306290 |
| P50 | author | Samuel V Scarpino | Q87279309 |
| Benjamin M Althouse | Q89291010 | ||
| P2860 | cites work | Relaxed phylogenetics and dating with confidence | Q21146068 |
| Evolution in health and medicine Sackler colloquium: a public choice framework for controlling transmissible and evolving diseases | Q24620815 | ||
| Incidence and Reproduction Numbers of Pertussis: Estimates from Serological and Social Contact Data in Five European Countries | Q27681116 | ||
| BEAST 2: a software platform for Bayesian evolutionary analysis | Q28660145 | ||
| jModelTest 2: more models, new heuristics and parallel computing | Q29546516 | ||
| Bias in pertussis incidence data and its implications for public health epidemiology | Q30576294 | ||
| A "new age" in pertussis prevention new opportunities through adult vaccination | Q33154808 | ||
| Estimating the duration of pertussis immunity using epidemiological signatures | Q33513972 | ||
| Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative | Q33777224 | ||
| Childhood vaccination in informal urban settlements in Nairobi, Kenya: who gets vaccinated? | Q33785403 | ||
| Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children | Q34013394 | ||
| Contagious diseases in the United States from 1888 to the present. | Q34246143 | ||
| The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection. | Q50560207 | ||
| The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. | Q50774329 | ||
| Binomial distribution based tau-leap accelerated stochastic simulation. | Q51557124 | ||
| Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. | Q52080230 | ||
| The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study. | Q53084808 | ||
| Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. | Q53087516 | ||
| The pertussis problem. | Q54406017 | ||
| Exact stochastic simulation of coupled chemical reactions | Q56536017 | ||
| Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection | Q57392965 | ||
| Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996 | Q64131608 | ||
| Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population | Q64134041 | ||
| Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial | Q68621441 | ||
| Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention | Q73333193 | ||
| Impact of immunisation on pertussis transmission in England and Wales | Q73449448 | ||
| Pertussis transmission in England and Wales | Q73761214 | ||
| Pathogen adaptation under imperfect vaccination: implications for pertussis | Q80946526 | ||
| Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model | Q34387963 | ||
| Duration of immunity against pertussis after natural infection or vaccination | Q34416409 | ||
| Epidemic cycles driven by host behaviour | Q34530779 | ||
| Timing of antimicrobial use influences the evolution of antimicrobial resistance during disease epidemics | Q34580194 | ||
| Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. | Q34881535 | ||
| Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial | Q35097262 | ||
| A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. | Q35533082 | ||
| Should the pertussis case definition for public health reporting be refined? | Q35854480 | ||
| Airborne transmission of Bordetella pertussis | Q36408279 | ||
| Birth-death skyline plot reveals temporal changes of epidemic spread in HIV and hepatitis C virus (HCV) | Q36512171 | ||
| Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? | Q37075063 | ||
| Can vaccine legacy explain the British pertussis resurgence? | Q37377866 | ||
| Unraveling the challenges of pertussis | Q37495317 | ||
| Immunisation and herd immunity | Q37582087 | ||
| Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. | Q37664578 | ||
| Global population structure and evolution of Bordetella pertussis and their relationship with vaccination | Q37714873 | ||
| Perplexities of pertussis: recent global epidemiological trends and their potential causes | Q38074502 | ||
| Possible options for new pertussis vaccines | Q38195759 | ||
| Live attenuated vaccines against pertussis | Q38236200 | ||
| Pertussis: increasing disease as a consequence of reducing transmission | Q40355489 | ||
| An age-structured model for pertussis transmission | Q40881745 | ||
| Epidemiological determinants of pertussis | Q41578325 | ||
| A two-phase within-host model for immune response and its application to serological profiles of pertussis | Q41614605 | ||
| Prevalence of asymptomatic Bordetella pertussis and Bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: a cross-sectional study | Q42228770 | ||
| Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort | Q42271276 | ||
| Pertactin-negative variants of Bordetella pertussis in the United States | Q42365877 | ||
| Epidemiological evidence for herd immunity induced by acellular pertussis vaccines | Q42432459 | ||
| Reply to Domenech de Cellès et al.: Infection and transmission of pertussis in the baboon model | Q42432467 | ||
| Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease | Q44503163 | ||
| Priming with whole-cell versus acellular pertussis vaccine | Q45080287 | ||
| Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection | Q46325996 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Bordetella pertussis | Q137103 |
| asymptomatic transmission | Q98114160 | ||
| P304 | page(s) | 146 | |
| P577 | publication date | 2015-06-24 | |
| P1433 | published in | BMC Medicine | Q4835947 |
| P1476 | title | Asymptomatic transmission and the resurgence of Bordetella pertussis | |
| P478 | volume | 13 |
| Q93150591 | A Network-Based Compartmental Model For The Spread Of Whooping Cough In Nebraska |
| Q47196558 | A New Whooping Cough Vaccine That May Prevent Colonization and Transmission |
| Q90721302 | A Retrospective Cohort Study of Safety Outcomes in New Zealand Infants Exposed to Tdap Vaccine in Utero |
| Q94468644 | A qPCR assay for Bordetella pertussis cells that enumerates both live and dead bacteria |
| Q64991935 | Age-appropriate compliance and completion of up to five doses of pertussis vaccine in US children. |
| Q41991590 | An Extracellular Polysaccharide Locus Required for Transmission of Bordetella bronchiseptica |
| Q50048492 | Bordetella pertussis (Bp) disease: Before (2003-2011) and after (2013-2016) maternal immunization strategy in a pediatric hospital. |
| Q92371395 | Clinical and epidemiological characteristics of whooping cough in hospitalized patients of a tertiary care hospital in Peru |
| Q36457650 | Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis |
| Q37521113 | Concentrations of Immunoglobulin G Antibodies Against Pertussis Toxin Does Not Decrease Over a Long Period of Time in Japan |
| Q50056769 | Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3. |
| Q55119556 | Contributions from the silent majority dominate dengue virus transmission. |
| Q90340982 | Controlled human infection with Bordetella pertussis induces asymptomatic, immunising colonisation |
| Q50067166 | Core pertussis transmission groups in England and Wales: A tale of two eras. |
| Q39005568 | Cost-effectiveness of next-generation vaccines: The case of pertussis |
| Q40517089 | Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies |
| Q93167136 | Development and Validation of a Bordetella pertussis Whole-Genome Screening Strategy |
| Q26747515 | Dismantling the Taboo against Vaccines in Pregnancy |
| Q61799827 | Does the economic recession influence the incidence of pertussis in a cosmopolitan European city? |
| Q50029708 | Effectiveness of acellular pertussis vaccine and evolution of pertussis incidence in the community of Madrid from 1998 to 2015. |
| Q52675967 | Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study. |
| Q39885983 | Epidemiological and Economic Effects of Priming With the Whole-Cell Bordetella pertussis Vaccine. |
| Q37485438 | Factors influencing the spread of pertussis in households: a prospective study, Catalonia and Navarre, Spain, 2012 to 2013. |
| Q52716180 | Fatal malignant pertussis with hyperleukocytosis in a Chinese infant: A case report and literature review. |
| Q33886984 | Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States |
| Q59632231 | IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine |
| Q40067718 | Identifying transmission routes of Streptococcus pneumoniae and sources of acquisitions in high transmission communities |
| Q40319379 | Immunity against vaccine-preventable diseases in Finnish pediatric healthcare workers in 2015. |
| Q64227318 | Immunization with whole cell but not acellular pertussis vaccines primes CD4 T cells that sustain protective immunity against nasal colonization with Bordetella pertussis |
| Q90643834 | Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis |
| Q36118682 | Investigating the pertussis resurgence in England and Wales, and options for future control |
| Q28552431 | Is Pertussis Infection Neglected in China? Evidence from a Seroepidemiology Survey in Zhejiang, an Eastern Province of China |
| Q40202103 | Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection |
| Q37036006 | Mechanism and Function of Type IV Secretion During Infection of the Human Host |
| Q64226531 | Neonatal Immunity to Infection and Current Prevention Strategies |
| Q35973016 | New Insight into Filamentous Hemagglutinin Secretion Reveals a Role for Full-Length FhaB in Bordetella Virulence |
| Q63370221 | PERISCOPE: road towards effective control of pertussis |
| Q40544517 | Parents as source of pertussis transmission in hospitalized young infants |
| Q40501690 | Pertussis Toxin Exploits Host Cell Signaling Pathways Induced by Meningitis-Causing E. coli K1-RS218 and Enhances Adherence of Monocytic THP-1 Cells to Human Cerebral Endothelial Cells. |
| Q39379357 | Pertussis and Rotavirus Vaccines - Controversies and Solutions |
| Q52600331 | Pertussis and the Minnesota State Fair: Demonstrating a Novel Setting for Efficiently Conducting Seroepidemiologic Studies. |
| Q38667218 | Pertussis disease and transmission and host responses: insights from the baboon model of pertussis |
| Q40769238 | Pertussis: acellular, whole-cell, new vaccines, what to choose? |
| Q40386628 | Population-Based Pertussis Incidence and Risk Factors in Infants Less Than 6 Months in Nepal |
| Q54230478 | Primary transcriptome analysis reveals importance of IS elements for the shaping of the transcriptional landscape of Bordetella pertussis. |
| Q50088219 | Public health measures for pertussis prevention and control. |
| Q40343067 | Quantifying the contribution of asymptomatic infection to the cumulative incidence |
| Q26744793 | Rediscovering Pertussis |
| Q97597401 | Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study |
| Q54243294 | School-age children and adolescents suspected of having been to be infected with pertussis in Japan. |
| Q57103953 | Seasonality of respiratory viruses causing hospitalizations for acute respiratory infections in children in Nha Trang, Vietnam |
| Q64104291 | Seroepidemiology of pertussis in Hangzhou, China, during 2009-2017 |
| Q59632234 | Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting TRM cells |
| Q92434100 | Systematic review and meta-analysis of pertussis epidemiology in Latin America and the Caribbean: 1980-2015 |
| Q89764757 | Tdap vaccination during pregnancy interrupts a twenty-year increase in the incidence of pertussis |
| Q41919766 | The BvgAS Regulon of Bordetella pertussis. |
| Q40061323 | The Pertussis resurgence: putting together the pieces of the puzzle |
| Q61448758 | The Role of Mucosal Immunity in Pertussis |
| Q51144168 | The impact of past vaccination coverage and immunity on pertussis resurgence. |
| Q26772095 | The pertussis enigma: reconciling epidemiology, immunology and evolution |
| Q97597405 | The potential for improved protection against pertussis |
| Q41588991 | The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis |
| Q90268591 | Toward a Controlled Human Infection Model of Pertussis |
| Q92239568 | Tracking U.S. Pertussis Incidence: Correlation of Public Health Surveillance and Google Search Data Varies by State |
| Q31112925 | Using Combined Diagnostic Test Results to Hindcast Trends of Infection from Cross-Sectional Data. |
| Q40295958 | What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines |
| Q47698503 | Will we have new pertussis vaccines? |
Search more.